For eligible families in Telangana, most of an ovarian cancer treatment plan — surgery, chemotherapy and the admissions around them — can be covered under Aarogyasri or PM-JAY at an empanelled hospital. Cover is not automatic. It depends on your card, on the hospital being empanelled for that treatment, and on an approval raised before treatment starts rather than after.
For an eligible family, yes — at a hospital empanelled for the scheme, against a listed package, with approval raised before treatment begins. All four of those conditions have to hold together, and that is why searching Aarogyasri ovarian cancer treatment returns so many contradictory answers. One family was covered end to end; another paid for most of it. Usually the difference is not the diagnosis. It is which hospital they walked into and when the paperwork was raised.
Two schemes are in play, and in Telangana they are run by the same body. Aarogyasri is the state scheme for eligible families, administered by the Aarogyasri Health Care Trust. Ayushman Bharat PM-JAY is the national entitlement, and the same trust is the state agency that delivers it here, so eligible families deal with one desk rather than two. Telangana raised the Aarogyasri cover for eligible families to ₹10 lakh per family per year in 2024. Limits and package lists are revised from time to time, so confirm the figure that applies to you at the hospital’s Aarogyasri Mithra help desk rather than from a news report.
It also helps to know what “covered” means here. The scheme does not pay your bill; it pays a fixed rate for a named package — a surgical procedure, a chemotherapy cycle by regimen type — at an empanelled hospital, and the treatment inside that package is cashless to you. Cover is granted per family per year, not per admission, so a relative’s earlier claim in the same year reduces what is left. Ovarian cancer treatment runs over months, which makes that arithmetic worth doing early. Our ovarian cancer treatment guide sets out the clinical sequence the packages are paying for.
Whether you qualify is decided by the trust from your ration card and scheme records, not by the hospital. Get that settled first — everything else follows it.
A hospital has to be empanelled for the treatment you need, not merely empanelled in general. Ask about the specific procedure, not the signboard.
Pre-authorisation is raised by the hospital and approved by the trust before treatment. “It will be covered” is not cover. Ask to see the approval.
Ayushman Bharat PM-JAY provides ₹5 lakh per family per year of cashless cover for secondary and tertiary hospitalisation at empanelled hospitals, and cancer surgery, chemotherapy and radiotherapy sit within its defined benefit packages rather than being paid against itemised bills. In Telangana the scheme is administered by the Aarogyasri Health Care Trust — the same state agency that runs Aarogyasri — so an eligible family is assessed once, through one help desk, rather than applying separately to two schemes. Source: National Health Authority, Ayushman Bharat PM-JAY scheme documents; Aarogyasri Health Care Trust, Government of Telangana.
Most families qualify under one of these. Work down the list until one describes your household, and take that card to the first consultation.
The state scheme covers eligible families in Telangana, with the white ration card as the usual basis of entitlement. It is administered by the Aarogyasri Health Care Trust, which decides eligibility, publishes the package list and approves each pre-authorisation. Cancer sits within its specialty packages, and cover is granted per family per year.
If your card details, Aadhaar and hospital records do not match, the approval stalls at exactly the point you least want a delay. Check the spelling of the name, the family members listed and the address before the first admission rather than on the morning of surgery.
PM-JAY provides ₹5 lakh per family per year of cashless cover at empanelled hospitals across India, with entitlement based on the scheme’s own beneficiary database and an Ayushman card issued after verification. Cancer surgery, chemotherapy and radiotherapy are among its defined packages.
In Telangana the benefit is delivered by the Aarogyasri Health Care Trust, so for most families the practical experience is the same desk and the same pre-authorisation process. The national card matters most if treatment is taken in another state, because PM-JAY is portable across empanelled hospitals in a way a state scheme is not.
Families resident in Andhra Pradesh come under the state’s own scheme rather than Aarogyasri, on broadly similar lines: an empanelled hospital, a listed package and approval before treatment. Many women travel to Hyderabad for treatment, so it is worth confirming early which state’s scheme your card belongs to.
The detail differs enough to matter, and it is set out separately in our guide to ovarian cancer treatment under NTR Vaidya Seva.
State government employees and pensioners in Telangana come under the Employees Health Scheme; central government employees under CGHS; ex-servicemen and dependants under ECHS; organised-sector workers under ESI. Each has its own empanelled hospital list, its own referral route and its own rates.
The common failure is the referral. These schemes usually require a referral or permission raised through the employing department or the scheme dispensary before admission, and a treatment started without it is difficult to regularise afterwards. Ask your department first, not last.
A private indemnity policy can cover an admission cashless at a network hospital when approval is obtained beforehand. Waiting periods, pre-existing-disease clauses and the treatment of day-care chemotherapy and take-home tablets all vary between policies, and they decide how much of a months-long ovarian cancer plan is actually reimbursed.
Families frequently hold both a scheme entitlement and a policy. Which one to use for which part of the treatment is a genuine decision, and it is worth making deliberately. See our guide to insurance and cashless cover for ovarian cancer.
Treatment does not have to be paid for in one lump. Ask for a written, itemised estimate after staging is complete, ask which lines are in-house and which will be billed by a partner centre, and ask what can be spread over instalments.
Ask for it before the first cycle rather than after the third, when the number is easier to plan around. Chemotherapy delivered close to home also removes months of travel and stay costs, which is a real part of the total for families outside Hyderabad.
The scheme pays for what is inside a named package. Almost every unpleasant surprise a family gets comes from the right-hand column, so it is worth reading that side first.
| Part of the treatment | Usually inside the scheme package | Commonly outside it |
|---|---|---|
| Diagnosis and staging | Investigations and the histopathology tied to a covered admission at the empanelled hospital. | Scans and tests done privately before you reach an empanelled hospital. Ask specifically whether a PET-CT is included for your package before booking one. |
| Surgery | The listed surgical-oncology package: theatre, the general-ward stay and the consumables the package names. | A semi-private or private room upgrade, and any item the package does not list. An upgrade can change how the whole claim is settled — ask before you accept one. |
| Chemotherapy | Cycles given against listed medical-oncology packages, at an empanelled centre, while cover remains for that family year. | Cycles taken at a hospital that is not empanelled, and cycles falling after the family cover for the year is exhausted. |
| Maintenance therapy | Assume nothing. Long-course tablets taken at home follow their own rules under scheme packages built around admissions. | Take-home oral drugs are the line families most often end up meeting themselves. Confirm it in writing before the first prescription. |
| Supportive care | Blood products, injections and admissions that fall inside a listed package. | Outpatient prescriptions, nutrition supplements, and the travel and stay costs of treatment away from home. |
| Follow-up and recurrence | Further admissions and further cycles, if cover remains in that family year. | Surveillance scans and clinic visits that are not attached to an admission. |
*Package names, rates and scheme limits are set by the trust and revised from time to time, and nothing here replaces what the hospital’s Aarogyasri Mithra help desk confirms for your own package on the day. Ask for the package name, what it includes, and what it leaves out — in writing, before treatment starts. For the full picture of what treatment itself costs, see our ovarian cancer treatment guide.
None of these is rare, and every one of them is preventable. They are the reasons families who were genuinely eligible still end up paying.
Pre-authorisation is raised before treatment, not claimed afterwards. A cycle given while the file is still “being processed” is the single commonest way cover is lost.
A hospital can be empanelled and still not carry the package your treatment needs. Ask about the specific procedure by name.
Cover for surgery says nothing about the tablets you take at home for the next many months. Ask which parts of the sequence are inside the package and which are not.
The limit is per family per year. A relative’s earlier claim in the same year reduces what is left for you, and ovarian cancer treatment runs long.
A misspelt name or an outdated address stalls an approval at the worst moment. Check the details before admission.
If surgery happens at one hospital and chemotherapy at another, each claim runs through that hospital’s own empanelment. Confirm both, separately, before either starts.
If any of these is already true for you, it is usually still fixable — but the time to fix it is before the next admission. Bring the card, the reports and any approval letters to the consultation, and we will go through them line by line alongside your insurance cover.
Send us the card you hold and the reports you already have. We will tell you what is likely to be covered, what is likely to sit outside the package, and what the rest is expected to cost. The first consultation is free and there is no obligation to move your treatment.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
The first consultation is free and runs to about 45 minutes. Aarogyasri, CGHS and cashless insurance are accepted where they apply, and we will say plainly what a scheme package does not include.
The process is more orderly than it looks from outside. Knowing the sequence lets you get the paperwork ready a week early instead of a week late.
White ration card, Ayushman card, an employee scheme card, or none of these. Take the card, an Aadhaar for the patient, and any earlier discharge summaries. If you are unsure whether the family is enrolled, the help desk at an empanelled hospital can check the beneficiary record for you rather than sending you to an office.
Every network hospital has an Aarogyasri Mithra help desk whose job is exactly this. Referrals from a government health facility or a scheme camp are one route in; families also present directly. Ask at this point whether the hospital carries the package for the treatment you are likely to need, because that answer decides where the rest of this happens.
A package cannot be raised against a suspicion. Imaging, and usually histopathology, have to establish what is being treated, and the treating team then maps the plan onto named packages — a surgical package, chemotherapy cycles, and so on. Ask for those names. They are what the approval will be written against.
The hospital uploads the case with the reports and the proposed package, and the trust approves, queries or rejects it. Nothing about this step is yours to do, but it is yours to verify. Ask to be told when approval has actually come through, and for how much and which package — not simply that it has been applied for.
Within an approved package at an empanelled hospital, the covered treatment is cashless to you. What falls outside it — a room upgrade, an unlisted consumable, an outpatient prescription — is billed to you, and should be told to you at the time rather than appearing at discharge. Ask for a running statement.
Chemotherapy cycles are typically authorised as they proceed rather than all at once, so the paperwork repeats. Keep every approval letter and discharge summary together. If the family cover for the year is used up part-way through treatment, say so early — instalments, a private policy or a fresh scheme year can be planned around, but only if the conversation happens before the next cycle.
*This describes the general shape of the process. The trust sets the rules, the packages and the limits, and they change; the hospital’s help desk is the authority on what applies to your case today.
Almost nobody funds ovarian cancer treatment from one source. A scheme covers the admissions, a policy covers part of the rest, savings cover the outpatient drugs, and instalments cover what is left. Knowing which cover applies to which part of the plan is what keeps the total manageable, and it is a conversation to have at the start rather than at the third cycle.
Be particularly careful about the months after chemotherapy ends. Maintenance therapy taken as tablets at home is the part that scheme packages and insurance policies treat least generously, and it is also the part that runs longest. If maintenance is likely for you, ask about its cover before the first prescription, not after it.
Your entitlement runs through NTR Vaidya Seva rather than Aarogyasri, even if you are treated in Hyderabad. The rules are similar but not identical.
Cashless approval at a network hospital covers most of an admission. Check how the policy treats day-care chemotherapy and take-home tablets — see our insurance guide.
The chemotherapy and maintenance months can usually be spread rather than paid upfront. Ask before the first cycle, when there is still room to plan.
Cycles given at a centre near you remove months of travel, stay and lost wages. That is a real part of the total, and it is the part nobody puts in an estimate.
Bring the scheme card, the policy document and any earlier claim details to the first consultation. A good half of what delays an approval is paperwork that could have been assembled a week earlier.
Cost and cover are usually the questions families ask last and worry about first. They belong in the same consultation as the diagnosis. Your first consultation at CION is free and runs to about 45 minutes — long enough to read the reports you bring, explain what the proposed plan is trying to achieve, and go through what a scheme is likely to cover and what it is not. Every case that raises a question is discussed at a tumour board rather than decided by one doctor, and tests that would not change the plan are not ordered.
We should be plain about who does what, because it decides whose empanelment your claim runs through. Delivered in-house at CION: chemotherapy and maintenance therapy across 35+ centres in Telangana and Andhra Pradesh, genetic counselling, BRCA and HRD testing, nutrition support and long-term follow-up. Cytoreductive and staging surgery, HIPEC, intraperitoneal chemotherapy and PET-CT are coordinated with specialist gynaecologic-oncology surgeons at partner centres and may be billed there, which means the scheme approval for the surgical part is raised by that centre against its own empanelment. That is worth confirming separately, before the operation is scheduled.
Aarogyasri, CGHS and cashless insurance are accepted where they apply, and our team helps check eligibility and prepare the paperwork. What we will not do is tell you a package covers something it does not. Decisions for healing, not billing, only means something if the billing is visible from the start.
Unhurried, with a specialist, and long enough to cover both the treatment plan and how it will be paid for.
We help check what you qualify for and prepare the pre-authorisation paperwork, so cover is confirmed before treatment rather than argued after it.
Cycles and follow-up delivered near where you live in Telangana and Andhra Pradesh, which removes months of travel from the real cost of treatment.
Where surgery is delivered at a partner centre, we say so upfront and tell you which claim runs through which hospital.
For eligible families, yes — at a hospital empanelled for the scheme, against a listed package, with pre-authorisation approved before treatment starts. Cancer sits within the scheme’s specialty packages, and surgery and chemotherapy given inside an approved package are cashless to you. Three things decide whether it actually works out. Your family has to be eligible, which the Aarogyasri Health Care Trust determines from its own records rather than the hospital deciding. The hospital has to be empanelled for the specific treatment, not merely empanelled in general. And the approval has to exist before the treatment, because claims are very difficult to regularise afterwards. Cover is granted per family per year, so an earlier claim by a relative in the same year reduces what remains for you.
The white ration card is the usual basis of entitlement for Aarogyasri in Telangana, and for most families it is the document the help desk asks for first. Eligibility itself is decided by the Aarogyasri Health Care Trust from the scheme’s beneficiary records, not by the hospital, so the practical step is to have the record checked rather than to assume from the card alone. Take the ration card, the patient’s Aadhaar and any earlier discharge summaries to the help desk at an empanelled hospital and ask them to verify enrolment. If the name spelling, family members listed or address do not match across documents, correct that before an admission rather than during one, because a mismatch stalls approval at exactly the wrong moment.
They are two schemes, but in Telangana they run through one door. Ayushman Bharat PM-JAY is the national entitlement, giving five lakh rupees per family per year of cashless cover at empanelled hospitals anywhere in India, with cancer surgery, chemotherapy and radiotherapy among its defined packages. Aarogyasri is the state scheme, and the Aarogyasri Health Care Trust is also the state agency that delivers PM-JAY here, so an eligible family is assessed once, at one help desk. Two practical differences are worth knowing. PM-JAY is portable, which matters if treatment is taken in another state. And the state scheme sets its own cover limit, which Telangana raised for eligible families in 2024; ask the help desk what limit currently applies to your family rather than relying on a figure read online.
Chemotherapy cycles given at an empanelled centre against a listed medical-oncology package are covered for eligible families, and are authorised as treatment proceeds rather than all at once, so the paperwork repeats with the cycles. Maintenance therapy is the part to ask about separately and in advance. Scheme packages are built around admissions and procedures, and long-course tablets taken at home carry their own rules; private policies also treat take-home drugs differently from an infusion given in a day-care chair. Since maintenance can run for many months, it is often the largest single line a family ends up meeting themselves. Ask for the position in writing before the first prescription, both from the scheme help desk and from your insurer, rather than discovering it at the pharmacy counter.
Yes, but each part is a separate claim through a separate empanelment, and that is where families get caught. If ovarian cancer surgery is done at one hospital and chemotherapy at another, the surgical package is raised by the operating hospital against its own empanelment, and the chemotherapy packages by the centre giving the cycles against theirs. Cover for one says nothing about cover for the other. Confirm both before either starts: that each hospital is empanelled for its part, and that pre-authorisation has actually been approved and not merely applied for. At CION this matters directly, because cytoreductive surgery is coordinated with specialist gynaecologic-oncology surgeons at partner centres and may be billed there, while chemotherapy and maintenance are delivered in-house.
Take the ration card or Ayushman card, the patient’s Aadhaar, and every report and discharge summary you already hold — scans, biopsy or histopathology reports, and any earlier approval letters. The help desk at an empanelled hospital works from these to verify enrolment and raise the pre-authorisation. On timing, the honest answer is that approval belongs before treatment. Schemes are designed around authorisation being raised and approved before an admission, and a cycle given while a file is still being processed is the commonest way cover is lost. If treatment has already begun without approval, say so plainly at the desk rather than hoping it resolves itself, and get the position clarified before the next admission or cycle.
The first consultation is free and runs to about 45 minutes. CION delivers medical oncology for ovarian cancer in-house — chemotherapy and maintenance therapy across more than 35 centres in Telangana and Andhra Pradesh, along with genetic counselling and BRCA and HRD testing where the diagnosis or family history warrants it. Cytoreductive surgery, HIPEC, intraperitoneal chemotherapy and PET-CT are coordinated with specialist gynaecologic-oncology surgeons at partner centres and may be billed there, so the scheme approval for that part is raised by the centre performing it. Aarogyasri, CGHS and cashless insurance are accepted where they apply, and our team helps check eligibility and prepare the paperwork. Every case that raises a question is reviewed at a tumour board.